help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on August 6, 2003, doi:10.1164/rccm.200301-111OC

Am. J. Respir. Crit. Care Med., Volume 168, Number 11, December 2003, 1304-1307

A more recent version of this article appeared on December 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200301-111OCv1
168/11/1304    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamazaki, K.
Right arrow Articles by Nishimura, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamazaki, K.
Right arrow Articles by Nishimura, M.

Submitted on February 5, 2003
Accepted on August 4, 2003

Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid

Koichi Yamazaki1*, Shigeaki Ogura2, Akitoshi Ishizaka3, Toshinari Oh-hara4, and Masaharu Nishimura1

1 First Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan, 2 Respiratory Disease, Sapporo City General Hospital, Sapporo, Japan; First Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan, 3 Medicine, Tokyo Electric Power Company Hospital, Tokyo, Japan, 4 Contract Research Department I, ADME/TOX Research Institute, Daiichi Pure Chemicals Co., Ltd., Tokyo, Japan

* To whom correspondence should be addressed. E-mail: kyamazak{at}med.hokudai.ac.jp.

Direct measurement of the concentration of antimicrobial agents in bronchial epithelial lining fluid (ELF) would allow for a more informed approach to appropriate dosing of antimicrobial agents for respiratory tract infections. In this study, we determined the time versus concentration profile in ELF after an oral administration of levofloxacin, using recently developed bronchoscopic microsampling (BMS) probes. These probes could be repeatedly and safely inserted through the fiberoptic bronchoscope in normal healthy volunteers. The concentration of levofloxacin in ELF was 43.4% of the corresponding serum value at 1 h, reached the same level at 2 h, decreased in a similar manner as that in serum and returned to undetectable levels at 24 h. It exceeded minimal inhibitory concentrations of Staphylococcus aureus (0.25 µg/ml), Klebsiella species (0.5 µg/ml), and Haemophilus influenzae (0.06 µg/ml) after 6 h. The experimental procedure was well tolerated and no complications were observed. In conclusion, BMS is a feasible and promising method for measuring antimicrobial concentrations in the target sites of respiratory tracts directly and repeatedly.


Key words: bronchoscopy, antimicrobial agents, respiratory tract infection, time versus concentration profile, levofloxacin




This article has been cited by other articles:


Home page
ChestHome page
E. Kipnis, K. Hansen, T. Sawa, K. Moriyama, A. Zurawel, A. Ishizaka, and J. Wiener-Kronish
Proteomic Analysis of Undiluted Lung Epithelial Lining Fluid
Chest, August 1, 2008; 134(2): 338 - 345.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Kiem and J. J. Schentag
Interpretation of Antibiotic Concentration Ratios Measured in Epithelial Lining Fluid
Antimicrob. Agents Chemother., January 1, 2008; 52(1): 24 - 36.
[Full Text] [PDF]


Home page
ChestHome page
M. Sasabayashi, Y. Yamazaki, K. Tsushima, O. Hatayama, and T. Okabe
Usefulness of Bronchoscopic Microsampling To Detect the Pathogenic Bacteria of Respiratory Infection
Chest, February 1, 2007; 131(2): 474 - 479.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Kotani, Y. Kotake, H. Morisaki, J. Takeda, H. Shimizu, T. Ueda, and A. Ishizaka
Activation of a Neutrophil-Derived Inflammatory Response in the Airways During Cardiopulmonary Bypass
Anesth. Analg., December 1, 2006; 103(6): 1394 - 1399.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. Hugues, L. Olivier, G. Benoit, B. Allaouchiche, E. Boselli, S. Gibot, B. Levy, and M.-C. Bene
Soluble TREM-1 and the Diagnosis of Pneumonia
N. Engl. J. Med., April 29, 2004; 350(18): 1904 - 1905.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Tuberculosis, Lung Infections, Interstitial Lung Disease, Social Issues and Journalology in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 288 - 300.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. N. Fish
Bronchoscopic Sampling of Drug Concentrations: Penetration to Tissue Is the Issue
Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1263 - 1265.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society